The CVC WAND offers the only air competent‡ valved, peelable introducer sheath on the market.
Designed to reduce the risks of bleeding, air embolism and catheter contamination, the CVC WAND offers hospitals and clinicians a unique opportunity to truly get to ZERO CLABSI.
Patented Nitinol, Air Competent Valve
Air Leakage = 0 cc/sec
(at - 55mmHg Vacuum Pressure)
The unique, valved introducer sheath of the CVC WAND is designed to prevent air embolism (a NEVER EVENT) and CLABSIs, while also creating a virtually bloodless procedure.
The novel design of the CVC WAND helps prevent the risks of central line insertion that have been associated with existing technology. It is the first and only safety introducer of its kind to provide valuable benefits for hospitals, practitioners and most importantly, patients.
The CVC WAND provides clinicians with two, effortless insertion methods (XL and AST) for delivery of their central lines. Both are… virtually bloodless.
The CVC WAND provides clinicians and physicians what they truly desire…
What potential benefits differentiate the design of CVC WAND from existing technologies?
| airguard+ | flowguard+ | CVC WAND++ | |
|---|---|---|---|
| Air Leakage | 0.15 cc/sec | 4.0 cc/sec | 0.0 cc/sec |
| + At -12 mmHg vacuum pressure ++ At -55 mmHg vacuum pressure |
|||
The CVC WAND is designed to reduce the unnecessary risks inherent with current Seldinger technique insertion of central lines.
During the most common procedure (seldinger technique) of CVC insertion, the catheter comes into direct contact with the skin as it enters into the vessel. These catheters have a 16.7% rate (5 in 30 patients) of bacterial surface contamination‡ which increases the risk of a CLABSI.
The CVC WAND offers the only air competent, peelable introducer sheath in the market. Since October 2008, CMC has deemed Intravascular Air Embolism a non-reimbursable event (a NEVER EVENT). The mortality rate from air embolism ranges from 23-50%‡.
